Finance

Beta
Lists
MXCT:NASDAQ
MaxCyte Inc
$1.24
-2.36%
(-0.030) 1D
$1.17
-5.65% (-0.070)
After hours
Closed: Jun 26, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MXCT...
Open
$1.27
High
$1.36
Low
$1.22
Mkt. cap
132.83M
Avg. vol.
1.24M
Volume
14.03M
52-wk high
$2.37
52-wk low
$0.64
EPS
-$0.37
Beta
1.48
Shares outstanding
107.12M
No. of employees
91
Open
$1.27
High
$1.36
Low
$1.22
Mkt. cap
132.83M
Avg. vol.
1.24M
Volume
14.03M
52-wk high
$2.37
52-wk low
$0.64
EPS
-$0.37
Beta
1.48
Shares outstanding
107.12M
No. of employees
91
News stories
From sources across the web
About MaxCyte Inc
CEO-
Employees91
Founded1998
HeadquartersRockville, Maryland, United States
SectorHealth care
Websitemaxcyte.com
Analyst ratings
Based on 5 analysts giving stock ratings to MXCT in the past 3 months
Buy
Buy
3
Hold
2
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for MXCT in the last 3 months.
Highest
Current $1.24
$4.00 (+222.58%)
Average
$4.00 (+222.58%)
Lowest
$4.00 (+222.58%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matt Hewitt
Craig-Hallum
Buy
Maintained
-
-
06/24/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
$4.00
+222.6%
05/13/2026
Matt Larew
William Blair
Hold
Maintained
-
-
05/13/2026
Mark Massaro
BTIG
Hold
Reiterated
-
-
05/13/2026
Brendan Smith
TD Cowen
Buy
Maintained
-
-
05/12/2026
Last report
May 12, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.04 / -$0.10
+57.89%beat
Revenue / Est. (USD)
9.65M / 7.30M
+32.24%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
8.51M
6.83M
7.30M
9.65M
Cost of goods sold
1.52M
1.60M
1.61M
1.57M
Cost of revenue
1.52M
1.60M
1.61M
1.57M
Research and development expenses
6.27M
5.32M
3.34M
3.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.87M
9.96M
8.24M
9.39M
Operating expense
21.22M
16.32M
12.61M
14.27M
Total operating expenses
22.73M
17.92M
14.22M
15.84M
Operating income
-14.23M
-11.09M
-6.92M
-6.18M
Other non operating income
-
-
-
-
EBT including unusual items
-12.36M
-12.42M
-9.60M
-4.75M
EBT excluding unusual items
-12.36M
-9.36M
-5.29M
-4.75M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12.36M
-12.42M
-9.60M
-4.75M
Net profit margin
-145.26%
-181.81%
-131.45%
-49.22%
Earnings per share
-0.12
-0.09
-0.06
-0.04
Interest and investment income
1.87M
1.73M
1.63M
1.44M
Interest expense
-
-
-
-
Net interest expenses
1.87M
1.73M
1.63M
1.44M
Depreciation and amortization charges
1.08M
1.04M
1.04M
1.02M
EBITDA
-13.14M
-10.03M
-5.86M
-5.14M
Gain or loss from assets sale
121.00K
34.00K
168.00K
14.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of MXCT
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer